Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory and neurological indications. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:FWP
CUSIPN/A
Phone45-3344-4242
Debt
Debt-to-Equity RatioN/A
Current Ratio17.23
Quick Ratio5.22
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$1.25 billion
Price / Sales0.09
Cash Flow$20.3333 per share
Price / Cash0.12
Book Value$1.90 per share
Price / Book1.28
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees5
Outstanding Shares47,180,000
Market Cap$112.30 million
Forward Pharma A/S (NASDAQ:FWP) Frequently Asked Questions
What is Forward Pharma A/S's stock symbol?
Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."
How were Forward Pharma A/S's earnings last quarter?
Forward Pharma A/S (NASDAQ:FWP) released its quarterly earnings results on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.26) by $0.06. View Forward Pharma A/S's Earnings History.
What price target have analysts set for FWP?
1 brokerages have issued 12 month price targets for Forward Pharma A/S's stock. Their predictions range from $6.00 to $6.00. On average, they anticipate Forward Pharma A/S's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 145.9% from the stock's current price. View Analyst Price Targets for Forward Pharma A/S.
What is the consensus analysts' recommendation for Forward Pharma A/S?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Forward Pharma A/S in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Forward Pharma A/S.
Who are some of Forward Pharma A/S's key competitors?
Some companies that are related to Forward Pharma A/S include Sinovac Biotech (SVA), Kindred Biosciences (KIN), ZIOPHARM Oncology (ZIOP), Syros Pharmaceuticals (SYRS), Dermira (DERM), Merus (MRUS), BioSpecifics Technologies (BSTC), Eidos Therapeutics (EIDX), resTORbio (TORC), Verrica Pharmaceuticals (VRCA), Synergy Pharmaceuticals (SGYP), Xeris Pharmaceuticals (XERS), Forty Seven (FTSV), Aquestive Therapeutics (AQST) and Evelo Biosciences (EVLO).
Who are Forward Pharma A/S's key executives?
Forward Pharma A/S's management team includes the folowing people:
- Dr. Claus Bo Svendsen M.D., Ph.D., CEO & Principal Financial Officer (Age 41)
- Mr. Thomas Carbone, Principal Accounting Officer, VP of Fin. and Controller (Age 61)
Who are Forward Pharma A/S's major shareholders?
Forward Pharma A/S's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (0.17%).
Which major investors are selling Forward Pharma A/S stock?
FWP stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.
How do I buy shares of Forward Pharma A/S?
Shares of FWP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Forward Pharma A/S's stock price today?
One share of FWP stock can currently be purchased for approximately $2.44.
How big of a company is Forward Pharma A/S?
Forward Pharma A/S has a market capitalization of $112.30 million and generates $1.25 billion in revenue each year. Forward Pharma A/S employs 5 workers across the globe.
What is Forward Pharma A/S's official website?
How can I contact Forward Pharma A/S?
Forward Pharma A/S's mailing address is Ostergade 24A 1, COPENHAGEN G7, 1100. The biotechnology company can be reached via phone at 45-3344-4242 or via email at [email protected]
MarketBeat Community Rating for Forward Pharma A/S (NASDAQ FWP)
MarketBeat's community ratings are surveys of what our community members think about Forward Pharma A/S and other stocks. Vote "Outperform" if you believe FWP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FWP will underperform the S&P 500 over the long term. You may vote once every thirty days.
